Replication of plasmid pIP501 is regulated at a step subsequent to transcription initiation by an antisense RNA (RNAIII) and transcriptionally by a repressor protein, CopR. Previously, it had been shown that CopR binds to a 44-bp DNA fragment upstream of and overlapping the repR promoter pII. Subsequently, we found that high-copy-number pIP501 derivatives lacking copR and low-copy-number derivatives containing copR produced the same intracellular amounts of RNAIII. This suggested a second, hitherto-unknown function of CopR. In this report, we show that CopR does not affect the half-life of RNAIII. Instead, we demonstrate in vivo that, in the presence of both pII and pIII, CopR provided in cis or in trans causes an increase in the intracellular concentration of RNAIII and that this effect is due to the function of the protein rather than its mRNA. We suggest that, in the absence of CopR, the increased (derepressed) RNAII transcription interferes, in cis, with initiation of transcription of RNAIII (convergent transcription), resulting in a lower RNAIII/plasmid ratio. When CopR is present, the pII promoter is repressed to >90%, so that convergent transcription is mostly abolished and RNAIII/plasmid ratios are high. The hypothesis that RNAII transcription influences promoter pIII through induced changes in DNA supercoiling is supported by the finding that the gyrase inhibitor novobiocin affects the accumulation of both sense and antisense RNA. The dual role of CopR in repression of RNAII transcription and in prevention of convergent transcription is discussed in the context of replication control of pIP501.
Replication of the broad-host-range plasmid pIP501 (19) is controlled at a step subsequent to transcription initiation by CopR (7) and posttranscriptionally by an antisense RNA (RNAIII) (11) . RNAIII induces transcriptional attenuation of RNAII within the leader region of the repR mRNA (11, 12) . CopR binds to a 44-bp sequence upstream of and partially overlapping the repR promoter pII, thereby repressing RNAII synthesis about 10-fold (7) . Deletion of copR resulted in a 10-to 20-fold increase of pIP501 copy number (9) , consistent with the elevated synthesis of RNAII, which encodes the rate-limiting RepR protein (10) . Recently, we measured the steady-state concentrations of RNAIII in Bacillus subtilis cells in high-copynumber and low-copy-number pIP501 derivatives. Since RNAIII is synthesized constitutively, its concentration should be directly correlated with plasmid copy number. Surprisingly, we found that this was not the case: both pPR1 (rnaIII ϩ copR; 50 to 100 copies/cell) and pCOP4 (rnaIII ϩ copR ϩ ; 5 to 10 copies/ cell) expressed about 1,000 to 2,000 molecules of RNAIII/cell (1.4 to 2.8 M [13] ). This suggested that, in addition to its function as a repressor of RNAII transcription, CopR is required for RNAIII accumulation. Previous analyses using transcriptional promoter-lacZ fusions ruled out the idea that CopR activates transcription from pIII (7) . Hence, CopR must act either by affecting the stability of RNAIII or by indirectly increasing transcription (see below).
In the case of the enterobacterial plasmid R1, a repressor protein (CopB) and an antisense RNA (CopA) are involved in controlling copy number (26) . Deletion of copB was shown to result in a decrease in total CopA activity. This was inferred to be due to a phenomenon called convergent transcription (31) , i.e., an effect of opposing transcriptional activity. Sense RNA transcription through the antisense promoter sequence interfered with normal copA expression. The original suggestion was that this effect was on the level of CopA termination, giving rise to longer (200-nucleotide [nt]) CopA transcripts that were presumed to be inactive in inhibition, but later work (4) indicated that CopA activity was decreased due to its lower intracellular concentration.
Convergent transcription may also occur in copR mutant derivatives of pIP501. If this is the case, repression of pII in the presence of CopR should permit an increase in RNAIII transcription.
The aim of our present work was to test this assumption. The following data reported here support the idea that convergent transcription occurs: (i) the half-life of RNAIII is independent of CopR; (ii) wild-type, but not a truncated, CopR protein supplied in cis or in trans affects RNAIII accumulation when the test plasmid encodes both rnaII and rnaIII; and (iii) a fourfold reduction of RNAIII levels by RNAII transcription is obtained only when rnaII and rnaIII are encoded in cis. Additionally, we show that a heterologous plasmid expressing only rnaIII exerted stronger incompatibility with wild-type pIP501 than one expressing both rnaII and rnaIII. Experiments with the gyrase inhibitor novobiocin indicated that transcription of RNAII and RNAIII was increased by the antibiotic, consistent with the possibility that the convergent transcription effect on RNAIII accumulation is on the level of induced alteration of DNA supercoiling in the pIII promoter region.
The activity of the copR gene product of pIP501 thus has a dual effect: (i) partial repression of the synthesis of RNAII results in decreased RepR synthesis, and (ii) prevention of convergent transcription allows for increased initiation frequency at the antisense promoter, thus amplifying the inhibitory effect. The interplay of the RNAIII and CopR parts of the regulatory circuit of copy number control of pIP501 is discussed.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Plasmids used in this study to construct new derivatives of pIP501 are listed in Table 1 . Plasmids were propagated in B. subtilis DB104 (20) , and Escherichia coli TG1 (27) was used for subcloning and mutagenesis. All strains were routinely grown at 37°C on tryptone-yeast (TY) medium. For the isolation of total RNA, DB104 transformants were cultivated on minimal medium containing Spizizen salts (1), 0.5% glucose, 0.2% Casamino Acids, and 5 mg of L-histidine per ml. DNA preparation and manipulation. DNA manipulations, restriction enzyme cleavage, ligation, labelling with kinase, etc., were carried out under the conditions specified by the manufacturer or according to standard protocols (27) . A GenAmp PCR kit from Perkin-Elmer/Cetus was used for PCRs. DNA sequencing was performed according to the dideoxy chain termination method (28) with a Sequenase kit from U.S. Biochemical.
Plasmid constructions. Plasmids for quantification of RNAIII, in the presence or absence of CopR provided in cis, and for the calculation of RNAII in the absence of RNAIII were constructed as follows. Plasmids pGTC4 and pGTC8 comprising pI, pII/IR1, and pIII/IR2 were constructed by cloning a 1.16-kb BamHI/SalI PCR fragment into BamHI/SalI-digested vector pGT1. To this end, plasmids pCOP4 and pCOP8 were used as PCR templates with oligonucleotides B 844-29 (5Ј TCTAGAGGATCCAAATTCCCACTAAGCGC) and B 845-31 (5Ј GAATTCGTCGACCGTCATGAAGCACAGTTTC), respectively. For the construction of plasmid pGT7, a single PCR step was performed on pPR7 DNA with oligonucleotides B 846-29 (5Ј GAATTCGGATCCAACAGAACCAGAACC AG) and B 845-31. The resulting 500-bp PCR fragment encompassing pII/IR1 and pIII/IR2 was cleaved with BamHI and SalI and inserted into pGT1 as described above.
A plasmid for tests of the effect of CopR on the half-life of RNAIII was constructed as follows. The CopR target region overlaps the last codon and the transcriptional terminator of the copR gene (7). To prevent CopR binding, we removed its last codon and the transcriptional terminator. Previous experiments showed that even longer truncations yield normal CopR activity in vivo (7a). Plasmid pGKIII/1 (13) was used to insert the copR gene as a BamHI fragment obtained by PCR on plasmid pCOP4 as template with oligonucleotides SB20 (5Ј GAATTCGGATCCTTAGAAATCATTGCTTTTTTCTTCTTCC) and SB21 (5Ј GAATTCGGATCCTGCAGCAAATTCCCACTAAGCGC 3Ј) into the unique BamHI site, resulting in plasmid pGKIIIC2 (copR gene in the same orientation as the rnaIII gene). Gel shift assays with crude extracts from DB104(pGKIIIC2) confirmed that plasmid pGKIIIC2 encodes a functional CopR protein that can bind to its DNA target (data not shown). This means that the deletion of the last copR codon did not affect the activity of CopR.
Plasmid pCBC⌬ was constructed to provide CopR in trans. The last codon and the transcriptional terminator of copR were replaced by a heterologous transcriptional terminator, thus destroying the CopR target. The construction was performed in three steps. First, a single PCR with oligonucleotides B 842-33 (5Ј AAGCTTGAATTCGTCGACTTCTAAAACGATGAG 3Ј) and SB22 (5Ј AAG CTTGAATTCTGCAGCTAGTCTCTACAACTAAG 3Ј) on pSU31 DNA, carrying the bidirectional terminator of the streptokinase region (30), gave a 100-bp fragment, which was cleaved with EcoRI and inserted into pUC19. Second, pTERM1, carrying the terminator in the correct orientation, was used to insert the BamHI fragment of plasmid pGKIIIC2 into the BamHI site of the pUC19 polylinker, resulting in plasmids pCOPT1 (copR gene in the proper orientation with respect to the terminator) and pCOPT2 (opposite orientation from insert). Since PCR introduced a PstI site at the 5Ј terminus of copR, the whole copR terminator segment could be subcloned as a PstI fragment into pUCB1, yielding pCBC⌬. Sequencing confirmed the orientation of the copR gene within pUCB1. The activity of CopR was again tested in crude extracts prepared from B. subtilis DB104(pCBC⌬).
Test for incompatibility. Strain DB104 carrying a wild-type pIP501 derivative (pGB354, Cm r ) was transformed with RNAIII or RNAII-RNAIII donor plasmids (pGKIII/1 and pGTW). Transformants were selected on erythromycin (EM), encoded on the incoming plasmid. Subsequently, 200 transformants were streaked in parallel on TY agar plates containing either EM or chloramphenicol. Additionally, 12 transformants for each plasmid were grown overnight on TY with EM, and plasmids were isolated.
Isolation of total RNA and Northern blot analyses. Isolation of total RNA, Northern blot analysis, and reprobing of the filters to correct loading errors were performed as described elsewhere (13) . For the determination of RNAIII halflife, rifampin was added to a final concentration of 100 g/ml to log-phase cultures and time samples were taken, frozen in liquid nitrogen, and used for the preparation of total RNA.
Novobiocin experiments. B. subtilis strains were grown on minimal medium to early exponential phase (optical density at 560 nm, 0.1 to 0.2); freshly prepared novobiocin (Sigma) was added to a final concentration of 10 g/ml; and time samples were taken after 10, 20, 30, 40, 50, and 60 min. A control culture was grown without novobiocin and harvested after 60 min. Samples were frozen on liquid nitrogen, and subsequent analyses were performed as described above.
RESULTS (i) CopR protein does not affect the half-life of RNAIII.
Since previous experiments showed that CopR provided in trans did not activate transcription initiation in pIII-lacZ fusions in the absence of the pII promoter (7), it was important to analyze whether the higher RNAIII levels accumulating from copR-proficient plasmids were due to a change in the stability of RNAIII. B. subtilis DB104 transformants harboring either plasmid pGKIII/1 (rnaIII ϩ copR) or pGKIIIC2 (rnaIII a The amount of RNAIII was corrected for loading errors (Materials and Methods). ϫ, corrected hybridization signal (pGTW); coefficients indicate the corresponding increase. Calculated values represent averages from five independent preparations. Figure 2 shows an example of such an analysis.
two plasmids permits an assessment of possible interactions between RNAIII and CopR without interference from other components of the replication machinery of pIP501. From the slope of semilogarithmic plots shown in Fig. 1 (lower panel) , the half-life of RNAIII was calculated to be 12 min (pGKIII/1) and 13 min (pGKIIIC2). The insignificant difference between these values suggests that CopR does not increase the metabolic stability of RNAIII.
(ii) Wild-type, but not truncated, CopR protein provided in cis or in trans increases the steady-state concentration of RNAIII. The pGK14 derivative pGT1 (compatible with pIP501) was used as a carrier of different fragments of the pIP501 replication region placed upstream of a heterologous transcriptional terminator (Materials and Methods). The resulting plasmids were called pGTC4 (rnaIII ϩ copR ϩ ), pGTC8 (rnaIII ϩ copR truncation) and pGTW (rnaIII ϩ copR). All inserted fragments contained pII, pIII, the terminator IR2, and 100 bp downstream of IR2. In the case of the pGTC derivatives, pI and the wild-type (pGTC4) or truncated (pGTC8) copR gene were present. The pGT1 derivatives do not depend on pIP501 elements to replicate in B. subtilis; hence, copy number effects on RNAIII concentration are eliminated. All plasmids were transferred into B. subtilis DB104, and total RNA was isolated and subjected to Northern blotting.
As shown in Fig. 2 and Table 2 , RNAIII was about fourfold more abundant in cells containing pGTC4 encoding an active CopR protein than in cells carrying pGTW (no copR) or pGTC8 (frameshift mutation in the copR gene). Apparently, the presence of a functional CopR protein permits the synthesis of higher intracellular amounts of RNAIII than those obtained in the absence of the protein.
A two-plasmid system was used to investigate whether the effect of intact CopR on the accumulation of RNAIII was indirect. The pIP501 copR gene lacking its own target region was inserted into pUCB1, resulting in pCBC⌬, to provide CopR in trans. A second plasmid was either pGTW containing a pII and a pIII/rnaIII segment or pGKIII/1 carrying only the rnaIII gene. Double plasmid strains were constructed, and Northern blot analyses were performed. Figure 3 and Table 3 indicate that RNAIII accumulation from pGKIII/1 is unaffected when CopR is supplied in trans, again supporting the idea that CopR does not activate transcription from pIII under conditions in which this promoter is isolated from pII (7). In contrast, Table 1 ). Arrows, direction of transcription; black boxes, promoters; stem loop, heterologous transcription terminator inserted 100 bp downstream of the pII attenuator and at the end of the copR⌬ gene. In the case of pCBC⌬, the terminator was used for correct transcription termination of the copR⌬ gene (in pCBC⌬), which lacks its own transcriptional terminator. Figure 3 and Table 3 also demonstrate clearly that active CopR permits RNAIII accumulation by repression of pII, allowing for higher transcriptional activity from pIII.
(iii) RNAII transcription affects RNAIII levels only if both are encoded on the same DNA segment. The results presented so far suggest that, whenever RNAII is transcribed in cis, the synthesis of RNAIII is decreased. If this is due to interference of the RNA polymerase transcribing the rnaII region with the activity of the pIII promoter, RNAII transcription from a second plasmid should not affect RNAIII accumulation. Figure 4 shows an experiment to test the effect of RNAII transcription in trans. Filters with immobilized, extracted RNA from strains carrying either a plasmid encoding only rnaIII (pCBW) or two plasmids encoding rnaII and rnaIII separately (pGT7 and pCBW) were probed for RNAIII, RNAII, and 5S rRNA (loading control). The quantification of the hybridization signals clearly showed that RNAII transcription of a second template fails to affect RNAIII accumulation significantly.
(iv) A plasmid expressing only rnaIII exerts stronger incompatibility with pIP501 than a plasmid expressing both rnaII and rnaIII. Since RNAIII is the major incompatibility determinant of pIP501, its activity can be measured independently from the Northern blot experiments above. Either one of the two plasmids, expressing only rnaIII (pGKIII/1) or both rnaII and rnaIII (pGTW), was introduced into B. subtilis to challenge a resident wild-type pIP501 derivative (pGB354) (see Materials and Methods for details). When only rnaIII was expressed from the incoming plasmid (pGKIII/1), only 12% of the tested transformants carried both plasmids, whereas expression of both rnaII and rnaIII (pGTW) failed to entail strong incompatibility (94% of the colonies still contained both plasmids). Accordingly, isolation of plasmids from 12 transformants grown overnight in liquid TY medium selecting for the incoming plasmid (pGKIII/1) showed no pGB354 (wild-type pIP501) plasmid band, whereas in the case of pGTW, 11 of 12 transformants contained both plasmids. Hence, pGTW is inefficient in displacing the wild-type pIP501 derivative after overnight cultivation, as expected from four-to fivefold-lower RNAIII accumulation when pII is present and active (see above and Fig. 3 and Table 3 ).
(v) The gyrase inhibitor novobiocin affects accumulation of RNAII and RNAIII. Bacterial promoters can vary with respect to their sensitivity to DNA supercoiling (e.g., 18, 29) . Novobiocin is an inhibitor of subunit B of DNA gyrase. To test whether transcription from pII or pIII and, hence, accumulation of RNAII and RNAIII are affected by changes in DNA supercoiling, B. subtilis DB104(pGKIII) (only pIII/rnaIII), DB104 (pGT7) (only pII; segment of rnaII), and DB104(pGTW) (both pII and pIII/rnaIII and segment of rnaII) were grown on minimal medium to early logarithmic phase, novobiocin was added to 10 g/ml, time samples were withdrawn, and RNA was isolated and subjected to Northern blot analysis. As shown in Fig.  5A , RNAIII levels (pGKIII/1) increased after 20 min of novobiocin treatment and remained at a two-to threefold-higher level until about 50 min. RNAII levels (pGT7) also increased at 10 min after addition of novobiocin and decreased between 50 and 60 min to the initial level. Since pGT7 does not produce RNAIII, and no second compatible plasmid providing RNAIII in trans was present in the cell, the fraction of terminated over readthrough RNAII remained unchanged.
When transcription occurred simultaneously from promoters pII and pIII (pGTW [ Fig. 5]) , RNAIII levels decreased about 10 to 20 min after addition of novobiocin, and-indicating lower inhibitory activity of RNAIII-the ratio of terminated (T) to full-length (F) RNAII transcripts (13) changed drastically, from 60 to 10% termination (Table 4) . Thus, transcriptional activity from pII through the pIII region causes a decrease in pIII activity (see above), and this effect dominates over that caused by novobiocin alone.
To circumvent the problem that the long half-life of RNAIII could mask an effect of supercoiling on de novo transcription, the experiment was repeated with pGK408 and pGT408. As the 408 mutant allele encodes an unstable variant of RNAIII (half-life of about 2 min) (13), one expects that rapid changes in RNAIII synthesis could be monitored more easily. As shown in Fig. 6 and Table 5 , the effect of novobiocin on the accumulation of RNAIII (pGK408; fivefold increase) was even more pronounced than in the case of pGKIII/1, indicating that initiation at pIII contributes greatly to the observed accumulation of RNAIII. In the case of pGT408 (transcription from both the sense and the antisense promoter), RNAIII accumulation was decreased in a manner similar to that in the case of pGTW. 
DISCUSSION
Previous studies showed that plasmid pIP501 is unusual in that it encodes a regulatory antisense RNA that is very stable (13) . We argued previously that long-lived antisense RNAs should be poor regulators since fortuitous decreases in plasmid copy number in individual cells would be only slowly corrected, resulting in unstable maintenance. The presence of the copR gene in pIP501 and the results presented in this communication indicate a strategy used by pIP501 to cope with the risk of unstable inheritance. We suggest that the effect of CopR is exerted, by the same molecular event, on two levels: transcriptional repression of repR mRNA synthesis and accumulation of RNAIII by prevention of convergent transcription.
A surprising result from previous work (13) was the similar intracellular concentrations of RNAIII in cells carrying either a high-copy-number copR mutant or a low-copy-number copR ϩ plasmid. This indicated that CopR either affected the stability of RNAIII or exerted another, more indirect effect on its synthesis. The results shown in Fig. 1 ruled out an effect on the metabolic stability of RNAIII. A comparison of the intracellular concentrations of RNAIII in the presence or absence of pII and the RNAIII target region and in the presence or absence of CopR in cis or in trans showed that accumulation of RNAIII was affected by RNAII transcription only in cis (Fig. 3  and 4 and Table 3 ). A key result is presented in Fig. 4 : synthesis of RNAII per se (for instance, if RNAII is provided in trans by pGT7) does not affect the concentration of RNAIII. In contrast, when transcription of RNAII is permitted in cis-either because the pII promoter is derepressed in the absence of copR (pGTW [ Fig. 2 and 3] ) or because the CopR protein is inactive due to truncation (pGTC8 [ Fig. 2] )-RNAIII levels are four-to fivefold lower than those in the absence of RNAII transcription (pGKIII [Fig. 3]) . Hence, transcriptional activity from the pII promoter rather than, e.g., RNAII-RNAIII interaction interferes with RNAIII synthesis. Functional tests were in line with the RNAII transcription-induced decrease of RNAIII concentration, since plasmid pGKIII/1 (only rnaIII) showed strong incompatibility with a resident pIP501 wild-type plasmid, whereas pGTW (rnaII/rnaIII) showed poor activity.
The phenomenon characterized by mutual or directional effects of opposing transcriptional activity on RNA synthesis is termed convergent transcription, and its effect on plasmid replication was first observed and described for the enterobacterial plasmid R1 (31) . The results presented here are probably pertinent to the same molecular events. The cis dependence of the decrease of the amount of antisense RNA on transcription of the sense RNA has, however, not been shown previously. Mechanistically, the results shown here suggest that the crucial factor in convergent transcription is the movement of the RNA polymerase towards or through the pIII promoter region. Three possibilities can be entertained: (i) promoter occlusion, (ii) colliding polymerases, and (iii) transcription-induced changes in DNA supercoiling affecting initiation of transcription from pIII. Promoter occlusion can be ruled out since the distance between the promoters pII and pIII suggests that simultaneous binding should be possible. The second model is not ruled out experimentally but is less likely since initiation from pIII is approximately as frequent as initiation from pII (supported by recent analysis of pII and pIII-lacZ transcriptional fusions [7] ), and, therefore, a hypothetical collision between RNA polymerases on the same DNA template should affect the levels of both transcripts. In addition, the concentrations of sense and antisense RNAs in plasmid-carrying B. subtilis cells and the half-lives of the RNAs suggest that RNA polymerases initiate at either of the two promoters for only a short fraction of the generation time. Thus, it appears unlikely that simultaneous initiation events occur on the same DNA template at a significant frequency. In contrast, it is probable that RNAII transcription, by passing through the pIII region, affects local DNA supercoiling. According to the twin supercoiled domain model for transcription (25) , regions of positive and negative supercoils are generated ahead of and behind, respectively, the transcribing polymerase. Such changes in DNA supercoiling affect many promoters (e.g., 5, 18, 29) . Antibiotics that target DNA gyrase, like novobiocin, therefore often alter promoter activity (18) . The effect of novobiocin shown in Fig.  5 and Table 4 indicates that pIII is supercoiling sensitive. Thus, we suggest that transcription-induced changes in DNA supercoiling may be responsible for the convergent transcription effect in plasmid pIP501. A variant of this model is that supercoiling per se is not the ultimate cause of a decrease in pIII activity, but that supercoiling-induced topological changes, e.g., cruciform extrusion (e.g., 6), at one of several inverted repeat sequences in or near the pIII promoter region (8) may decrease initiation frequency. More work will be required to elucidate the details of the mechanism. Irrespective of the molecular mechanism by which convergent transcription occurs, the results presented here suggest a way by which plasmid pIP501 can use the concerted action of RNAIII and the CopR protein to efficiently regulate its copy number. RNAIII alone is able to correct increases in copy number: At higher plasmid concentrations, more RNAIII is synthesized, which in turn increases transcriptional attenuation of RNAII, thus decreasing the replication frequency. In contrast, fortuitous copy number decreases cannot rapidly be corrected by RNAIII, since its long half-life (13) will result in a disproportionately high concentration of the inhibitor, which threatens to yield a replication frequency inappropriately low for the current copy number. CopR, due to its dual effect indicated above, acts in a complementary fashion to correct downward fluctuations in plasmid concentration: decreased synthesis of CopR will derepress the pII promoter. This single event of derepression has two consequences: (i) increased transcription of RNAII (12) and (ii) convergent transcription, which decreases transcription of RNAIII. Both effects increase RepR synthesis and, consequently, the replication frequency: i.e., the molecular event of derepression of the pII promoter works as an amplifier. The dual effect of CopR, together with the previously recognized importance of the antisense RNA RNAIII, suggests the model for pIP501 copy number control shown in Fig. 7 . Based on the concerted action of these two regulatory elements, the stable inheritance of pIP501 can be accounted for. Plasmids pSM19035 (2) and pAM␤1 (14) , which share the overall organization of pIP501 (inc18 plasmid family [8] ) as well as the same mode of regulation (e.g., 22, 23) , may employ the same strategy to secure their stable maintenance.
Several other plasmids carry both antisense RNAs and repressor proteins as copy number control genes, e.g., plasmids R1 (26) and pLS1 (15) . Functional analysis of CopB of plasmid R1 indicated that, although it prevents convergent transcription in a manner similar to that of CopR of pIP501, its primary role is that of a rescue device at dangerously low copy numbers and/or after conjugal transfer of R1 (24) . During normal steady-state conditions, the short half-life of CopA (28a) is sufficient to cope with copy number deviations. In the case of pLS1, CopG and the antisense RNA (RNAII) act independently, and the combined action of both elements is required for copy number regulation (16) . So far, no half-life has been determined for RNAII (17) , nor is it clear whether CopG is required for stable maintenance. RNAII concentrations were reported to correlate approximately with the copy numbers of FIG. 6 . Effect of novobiocin on accumulation of RNAIII 408 (half-life mutant) in the presence or absence of transcription from promoters pII and pIII. The Northern blot is shown. Samples were taken at the indicated times after novobiocin addition or without novobiocin (⌬). Hybridization, reprobing for 5S rRNA, and calculations were done as described in Materials and Methods. Plasmids and promoters are indicated. a Calculation of relative amounts of RNAII and RNAIII and determination of percent termination were done as for Table 2 . Note that plasmid pGT7 expresses only RNAII, whereas plasmid pGTW expresses both RNAII and RNAIII. x, corrected hybridization signal at 0 min for RNAIII (pGTW); y, corrected hybridization signal at 0 min for RNAII (pGTW); coefficients indicate the corresponding increase or decrease. Figure 5 shows the autoradiogram of the corresponding gel. Figure  6 shows the autoradiogram of the corresponding gel. the corresponding derivatives: copG-deficient plasmids replicating at a fivefold-higher copy number produced threefold more RNAII than the wild-type plasmid (17) . This may indicate that CopG does not significantly affect antisense RNA levels by convergent transcription. A similar mode of regulation can be inferred for the other plasmids of the pLS1 family, such as pE194, pADB201, etc. (16) .
In summary, we can conclude that the inc18 plasmids represented by pIP501-in contrast to other antisense RNA-regulated plasmids-may have evolved a specific strategy to ensure stable plasmid maintenance that employs the concerted action of an unusually stable antisense RNA and a transcriptional repressor protein with a dual function.
